These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 30842147)

  • 1. Liprin-α4 as a New Therapeutic Target for SCLC as an Upstream Mediator of HIF1α.
    Onishi H; Yamasaki A; Nakamura K; Ichimiya S; Yanai K; Umebayashi M; Nagai S; Morisaki T
    Anticancer Res; 2019 Mar; 39(3):1179-1184. PubMed ID: 30842147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liprin-α4 as a Possible New Therapeutic Target for Pancreatic Cancer.
    Yamasaki A; Nakayama K; Imaizumi A; Kawamoto M; Fujimura A; Oyama Y; Nagai S; Yanai K; Onishi H
    Anticancer Res; 2017 Dec; 37(12):6649-6654. PubMed ID: 29187440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liprin-α4 is a new hypoxia-inducible target gene required for maintenance of cell-cell contacts.
    Mattauch S; Sachs M; Behrens J
    Exp Cell Res; 2010 Oct; 316(17):2883-92. PubMed ID: 20599943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myc-induced glutaminolysis bypasses HIF-driven glycolysis in hypoxic small cell lung carcinoma cells.
    Munksgaard Thorén M; Vaapil M; Staaf J; Planck M; Johansson ME; Mohlin S; Påhlman S
    Oncotarget; 2017 Jul; 8(30):48983-48995. PubMed ID: 28430666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIF-2α expression is suppressed in SCLC cells, which survive in moderate and severe hypoxia when HIF-1α is repressed.
    Munksgaard Persson M; Johansson ME; Monsef N; Planck M; Beckman S; Seckl MJ; Rönnstrand L; Påhlman S; Pettersson HM
    Am J Pathol; 2012 Feb; 180(2):494-504. PubMed ID: 22115707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liprin-α4 is required for nickel induced receptor protein tyrosine phosphatase-leukocyte antigen related receptor F (RPTP-LAR) activity.
    Kiok K; Sun H; Clancy H; Bose S; Kluz T; Wu F; Costa M
    PLoS One; 2011; 6(8):e22764. PubMed ID: 21829649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways.
    Wan J; Wu W
    J Exp Clin Cancer Res; 2016 Jul; 35(1):119. PubMed ID: 27456341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-Regulated microRNA-125-HER2 Pathway as a Novel Therapeutic Target for Trastuzumab-Mediated Cellular Cytotoxicity in Small Cell Lung Cancer.
    Yagishita S; Fujita Y; Kitazono S; Ko R; Nakadate Y; Sawada T; Kitamura Y; Shimoyama T; Maeda Y; Takahashi F; Takahashi K; Tamura T; Koizumi F
    Mol Cancer Ther; 2015 Jun; 14(6):1414-23. PubMed ID: 25833836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
    Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
    FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor-1α and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study.
    Lee GW; Go SI; Cho YJ; Jeong YY; Kim HC; Duk Lee J; Hwang YS; Ko GH; Lee JH; Kim DC; Yang JW; Oh S; Lee JS
    J Thorac Oncol; 2012 Mar; 7(3):528-34. PubMed ID: 22258474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of RNA interference targeting hypoxia-inducible factor-1alpha on chemosensitivity in esophageal squamous cell carcinoma cells under hypoxia].
    Wu XA; Sun Y; Fan QX; Wang LX; Wang RL; Zhang L
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2640-4. PubMed ID: 18162154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER2 as therapeutic target for overcoming ATP-binding cassette transporter-mediated chemoresistance in small cell lung cancer.
    Minami T; Kijima T; Otani Y; Kohmo S; Takahashi R; Nagatomo I; Hirata H; Suzuki M; Inoue K; Takeda Y; Kida H; Tachibana I; Kumanogoh A
    Mol Cancer Ther; 2012 Apr; 11(4):830-41. PubMed ID: 22389470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization.
    Fischer C; Leithner K; Wohlkoenig C; Quehenberger F; Bertsch A; Olschewski A; Olschewski H; Hrzenjak A
    Mol Cancer; 2015 Jan; 14():4. PubMed ID: 25608569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus-mediated siRNA targeting c-Met inhibits proliferation and invasion of small-cell lung cancer (SCLC) cells.
    Wang ZX; Lu BB; Yang JS; Wang KM; De W
    J Surg Res; 2011 Nov; 171(1):127-35. PubMed ID: 20338593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA‑214 upregulates HIF‑1α and VEGF by targeting ING4 in lung cancer cells.
    Li Y; Zhao L; Qi Y; Yang X
    Mol Med Rep; 2019 Jun; 19(6):4935-4945. PubMed ID: 31059086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of p62/SQSTM1 sensitizes small-cell lung cancer cells to cisplatin-induced cytotoxicity by targeting NEDD9 expression.
    Xu L; Xu F; Kong Q; Yang T; Tan D; Zhang X; Li N; Zhao S; Zhao J; Li M
    Mol Carcinog; 2020 Aug; 59(8):967-979. PubMed ID: 32424979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allicin Overcomes Hypoxia Mediated Cisplatin Resistance in Lung Cancer Cells through ROS Mediated Cell Death Pathway and by Suppressing Hypoxia Inducible Factors.
    Pandey N; Tyagi G; Kaur P; Pradhan S; Rajam MV; Srivastava T
    Cell Physiol Biochem; 2020 Aug; 54(4):748-766. PubMed ID: 32809300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIF Inactivation of p53 in Ovarian Cancer Can Be Reversed by Topotecan, Restoring Cisplatin and Paclitaxel Sensitivity.
    Parmakhtiar B; Burger RA; Kim JH; Fruehauf JP
    Mol Cancer Res; 2019 Aug; 17(8):1675-1686. PubMed ID: 31088908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous interference of SP1 and HIF1α retarding the proliferation, migration, and invasion of human microvascular endothelial cells (HMEC-1) under hypoxia.
    Ai L; Lin S; Huang C; Gao L; Zhou J; Chen C; Ye J
    J Cell Biochem; 2019 Oct; 120(10):17912-17925. PubMed ID: 31135072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.